Nexgenia’s new CEO shifts focus to cell separations and immunotherapy product development. Read the press release from the UW C4C below.
Nexgenia News Release
Nexgenia’s new CEO shifts focus to cell separations and immunotherapy product development. Read the press release from the UW C4C below.
Nexgenia News Release
Comments are closed.